Published in BMC Genomics on March 15, 2007
Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation. Nat Biotechnol (2012) 3.07
Txnip balances metabolic and growth signaling via PTEN disulfide reduction. Proc Natl Acad Sci U S A (2008) 2.41
Targeting long non-coding RNA to therapeutically upregulate gene expression. Nat Rev Drug Discov (2013) 1.82
Variability in training-induced skeletal muscle adaptation. J Appl Physiol (1985) (2010) 1.75
Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes. Genome Med (2010) 1.64
RNPomics: defining the ncRNA transcriptome by cDNA library generation from ribonucleo-protein particles. Nucleic Acids Res (2010) 1.13
Tickled PINK1: mitochondrial homeostasis and autophagy in recessive Parkinsonism. Biochim Biophys Acta (2009) 1.09
Non-protein coding RNA biomarkers and differential expression in cancers: a review. J Exp Clin Cancer Res (2008) 1.06
Trans-natural antisense transcripts including noncoding RNAs in 10 species: implications for expression regulation. Nucleic Acids Res (2008) 1.03
Non-coding RNA transcripts: sensors of neuronal stress, modulators of synaptic plasticity, and agents of change in the onset of Alzheimer's disease. Neurosci Lett (2009) 0.96
Natural antisense transcripts. Hum Mol Genet (2014) 0.94
The landscape of antisense gene expression in human cancers. Genome Res (2015) 0.91
Expression of non-protein-coding antisense RNAs in genomic regions related to autism spectrum disorders. Mol Autism (2013) 0.88
Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma. Pharmacol Ther (2016) 0.87
Expression analysis of the long non-coding RNA antisense to Uchl1 (AS Uchl1) during dopaminergic cells' differentiation in vitro and in neurochemical models of Parkinson's disease. Front Cell Neurosci (2015) 0.86
The mitochondrial kinase PINK1, stress response and Parkinson's disease. J Bioenerg Biomembr (2009) 0.84
Epigenetic regulation in Parkinson's disease. Acta Neuropathol (2016) 0.83
A novel collection of snRNA-like promoters with tissue-specific transcription properties. Int J Mol Sci (2012) 0.83
RNA metabolism in the pathogenesis of Parkinson׳s disease. Brain Res (2014) 0.79
Natural antisense transcripts as therapeutic targets. Drug Discov Today Ther Strateg (2013) 0.77
Insights from the HuR-interacting transcriptome: ncRNAs, ubiquitin pathways, and patterns of secondary structure dependent RNA interactions. Mol Genet Genomics (2012) 0.77
miRNAs and their putative roles in the development and progression of Parkinson's disease. Front Genet (2013) 0.77
Cis-Natural Antisense Transcripts Are Mainly Co-expressed with Their Sense Transcripts and Primarily Related to Energy Metabolic Pathways during Muscle Development. Int J Biol Sci (2016) 0.76
Molecular studies of exercise, skeletal muscle, and ageing. F1000Res (2016) 0.75
Exploiting Long Noncoding RNAs as Pharmacological Targets to Modulate Epigenetic Diseases. Yale J Biol Med (2017) 0.75
Cocaine alters Homer1 natural antisense transcript in the nucleus accumbens. Mol Cell Neurosci (2017) 0.75
Noncoding RNAs in neurodegeneration. Nat Rev Neurosci (2017) 0.75
Long Noncoding RNAs and RNA-Binding Proteins in Oxidative Stress, Cellular Senescence, and Age-Related Diseases. Oxid Med Cell Longev (2017) 0.75
Ampk phosphorylation of Ulk1 is required for targeting of mitochondria to lysosomes in exercise-induced mitophagy. Nat Commun (2017) 0.75
JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res (2004) 19.32
Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science (2004) 15.91
Antisense transcription in the mammalian transcriptome. Science (2005) 15.69
The pathophysiology of mitochondrial cell death. Science (2004) 13.87
Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature (2006) 11.91
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature (2006) 11.81
Mitochondrial dysfunction and type 2 diabetes. Science (2005) 10.25
A strategy for probing the function of noncoding RNAs finds a repressor of NFAT. Science (2005) 9.25
Widespread occurrence of antisense transcription in the human genome. Nat Biotechnol (2003) 8.54
The non-coding Air RNA is required for silencing autosomal imprinted genes. Nature (2002) 7.37
Kalign--an accurate and fast multiple sequence alignment algorithm. BMC Bioinformatics (2005) 7.01
Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat Biotechnol (2005) 5.99
Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc Natl Acad Sci U S A (2006) 5.78
ConSite: web-based prediction of regulatory elements using cross-species comparison. Nucleic Acids Res (2004) 4.99
Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nat Rev Neurosci (2006) 4.87
A new generation of JASPAR, the open-access repository for transcription factor binding site profiles. Nucleic Acids Res (2006) 4.32
Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. Proc Natl Acad Sci U S A (2005) 4.22
In search of antisense. Trends Biochem Sci (2004) 3.93
The biochemistry of Parkinson's disease. Annu Rev Biochem (2005) 3.79
Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum Mol Genet (2005) 3.76
Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol (2004) 3.67
MODBASE: a database of annotated comparative protein structure models and associated resources. Nucleic Acids Res (2006) 3.56
Specific and potent RNAi in the nucleus of human cells. Nat Struct Mol Biol (2005) 3.16
Exercise stimulates Pgc-1alpha transcription in skeletal muscle through activation of the p38 MAPK pathway. J Biol Chem (2005) 3.06
Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology (2005) 2.74
PINK1 protein in normal human brain and Parkinson's disease. Brain (2006) 2.49
Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J Biol Chem (2005) 2.26
Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway. Oncogene (2001) 2.25
Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila. Proc Natl Acad Sci U S A (2006) 2.08
Kinase signaling cascades in the mitochondrion: a matter of life or death. Free Radic Biol Med (2005) 1.93
Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress. J Neurochem (2006) 1.91
Human muscle gene expression responses to endurance training provide a novel perspective on Duchenne muscular dystrophy. FASEB J (2005) 1.85
Small RNA asymmetry in RNAi: function in RISC assembly and gene regulation. FEBS Lett (2005) 1.74
Small interfering RNA targeting the PINK1 induces apoptosis in dopaminergic cells SH-SY5Y. Biochem Biophys Res Commun (2005) 1.64
Regulation of gene expression by natural antisense RNA transcripts. Neurochem Int (1997) 1.54
The influence of non-coding RNAs on allele-specific gene expression in mammals. Hum Mol Genet (2005) 1.46
Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells. Proc Natl Acad Sci U S A (2004) 1.39
BRPK, a novel protein kinase showing increased expression in mouse cancer cell lines with higher metastatic potential. Cancer Lett (2003) 1.38
NATsDB: Natural Antisense Transcripts DataBase. Nucleic Acids Res (2006) 1.33
Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults. Arch Neurol (2005) 1.33
Substrate availability limits human skeletal muscle oxidative ATP regeneration at the onset of ischemic exercise. J Clin Invest (1998) 1.19
Does everything now make (anti)sense? Biochem Soc Trans (2006) 1.12
Antisense transcript and RNA processing alterations suppress instability of polyadenylated mRNA in chlamydomonas chloroplasts. Plant Cell (2004) 0.97
Antisense WT1 transcription parallels sense mRNA and protein expression in fetal kidney and can elevate protein levels in vitro. J Pathol (1998) 0.91
Effect of prolonged mechanical ventilation on diaphragm muscle mitochondria in piglets. Acta Anaesthesiol Scand (2005) 0.82
Pfam: clans, web tools and services. Nucleic Acids Res (2006) 34.83
Landscape of transcription in human cells. Nature (2012) 20.18
Genome-wide analysis of mammalian promoter architecture and evolution. Nat Genet (2006) 17.19
The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res (2012) 15.41
A promoter-level mammalian expression atlas. Nature (2014) 6.25
An atlas of combinatorial transcriptional regulation in mouse and man. Cell (2010) 6.24
The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line. Nat Genet (2009) 6.02
The regulated retrotransposon transcriptome of mammalian cells. Nat Genet (2009) 5.79
Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med (2008) 5.62
Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages. Proc Natl Acad Sci U S A (2007) 4.69
Regulatory roles of natural antisense transcripts. Nat Rev Mol Cell Biol (2009) 4.48
Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A (2002) 4.20
Tiny RNAs associated with transcription start sites in animals. Nat Genet (2009) 4.19
Complex Loci in human and mouse genomes. PLoS Genet (2006) 3.74
Retinoblastoma protein functions as a molecular switch determining white versus brown adipocyte differentiation. Proc Natl Acad Sci U S A (2004) 3.45
The reality of pervasive transcription. PLoS Biol (2011) 3.41
Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes (2002) 3.21
Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation. Nat Biotechnol (2012) 3.07
Small RNAs derived from snoRNAs. RNA (2009) 3.04
An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA. Nature (2009) 3.04
Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance. PLoS Biol (2006) 2.86
RNAdb--a comprehensive mammalian noncoding RNA database. Nucleic Acids Res (2005) 2.84
Recruited vs. nonrecruited molecular signatures of brown, "brite," and white adipose tissues. Am J Physiol Endocrinol Metab (2011) 2.78
Using molecular classification to predict gains in maximal aerobic capacity following endurance exercise training in humans. J Appl Physiol (1985) (2010) 2.74
Amino acid concentrations in critically ill children following cardiac surgery*. Pediatr Crit Care Med (2014) 2.65
Striatal microRNA controls cocaine intake through CREB signalling. Nature (2010) 2.56
Linking promoters to functional transcripts in small samples with nanoCAGE and CAGEscan. Nat Methods (2010) 2.30
Genome-wide analysis of promoter architecture in Drosophila melanogaster. Genome Res (2010) 2.29
A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites. Nucleic Acids Res (2005) 2.27
High responders to resistance exercise training demonstrate differential regulation of skeletal muscle microRNA expression. J Appl Physiol (1985) (2010) 2.25
Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality. Nucleic Acids Res (2005) 2.20
Hypoxia-independent angiogenesis in adipose tissues during cold acclimation. Cell Metab (2009) 2.11
Extremely short duration high intensity interval training substantially improves insulin action in young healthy males. BMC Endocr Disord (2009) 2.09
Evidence for natural antisense transcript-mediated inhibition of microRNA function. Genome Biol (2010) 2.08
Inhibition of Staphylococcus aureus gene expression and growth using antisense peptide nucleic acids. Mol Ther (2004) 2.08
A transcriptional map of the impact of endurance exercise training on skeletal muscle phenotype. J Appl Physiol (1985) (2010) 2.07
MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction. Proc Natl Acad Sci U S A (2009) 2.00
Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells. Science (2015) 1.91
Considerations when using the significance analysis of microarrays (SAM) algorithm. BMC Bioinformatics (2005) 1.89
Human muscle gene expression responses to endurance training provide a novel perspective on Duchenne muscular dystrophy. FASEB J (2005) 1.85
A small molecule enhances RNA interference and promotes microRNA processing. Nat Biotechnol (2008) 1.80
Unamplified cap analysis of gene expression on a single-molecule sequencer. Genome Res (2011) 1.79
Amygdala-dependent fear is regulated by Oprl1 in mice and humans with PTSD. Sci Transl Med (2013) 1.74
Effects on skeletal muscle of intravenous glutamine supplementation to ICU patients. Intensive Care Med (2004) 1.73
Cross-mapping and the identification of editing sites in mature microRNAs in high-throughput sequencing libraries. Genome Res (2010) 1.73
Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide. J Lipid Res (2009) 1.70
5' end-centered expression profiling using cap-analysis gene expression and next-generation sequencing. Nat Protoc (2012) 1.70
Distinct expression of muscle-specific microRNAs (myomirs) in brown adipocytes. J Cell Physiol (2009) 1.67
Glutamine and glutathione at ICU admission in relation to outcome. Clin Sci (Lond) (2012) 1.65
Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes. Genome Med (2010) 1.64
Improved and automated prediction of effective siRNA. Biochem Biophys Res Commun (2004) 1.58
Gateways to the FANTOM5 promoter level mammalian expression atlas. Genome Biol (2015) 1.58
A novel RNA transcript with antiapoptotic function is silenced in fragile X syndrome. PLoS One (2008) 1.57
Dysregulation of mitochondrial dynamics and the muscle transcriptome in ICU patients suffering from sepsis induced multiple organ failure. PLoS One (2008) 1.52
MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function. Proc Natl Acad Sci U S A (2012) 1.49
Pseudo-messenger RNA: phantoms of the transcriptome. PLoS Genet (2006) 1.46
Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment. PLoS One (2009) 1.46
Regulation of chromatin structure by long noncoding RNAs: focus on natural antisense transcripts. Trends Genet (2012) 1.46
Reduced oxidative power but unchanged antioxidative capacity in skeletal muscle from aged humans. Pflugers Arch (2003) 1.44
Thermogenically competent nonadrenergic recruitment in brown preadipocytes by a PPARgamma agonist. Am J Physiol Endocrinol Metab (2008) 1.43
PPARgamma in the control of brown adipocyte differentiation. Biochim Biophys Acta (2005) 1.42
Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish caucasians. Diabetes (2004) 1.41
Analysis of the DNA methylome and transcriptome in granulopoiesis reveals timed changes and dynamic enhancer methylation. Blood (2014) 1.36
MicroRNA dysregulation in psychiatric disease. Brain Res (2010) 1.34
FANTOM4 EdgeExpressDB: an integrated database of promoters, genes, microRNAs, expression dynamics and regulatory interactions. Genome Biol (2009) 1.32
The importance of brown adipose tissue. N Engl J Med (2009) 1.31
Derangements in mitochondrial metabolism in intercostal and leg muscle of critically ill patients with sepsis-induced multiple organ failure. Am J Physiol Endocrinol Metab (2006) 1.31
Systematic analysis of adaptations in aerobic capacity and submaximal energy metabolism provides a unique insight into determinants of human aerobic performance. J Appl Physiol (1985) (2009) 1.31
Effects of cytosine methylation on transcription factor binding sites. BMC Genomics (2014) 1.31
Uncoupling proteins: a role in protection against reactive oxygen species--or not? Biochim Biophys Acta (2006) 1.30
Apoptosis resistance downstream of eIF4E: posttranscriptional activation of an anti-apoptotic transcript carrying a consensus hairpin structure. Nucleic Acids Res (2006) 1.27
Noncoding RNAs: couplers of analog and digital information in nervous system function? Trends Neurosci (2007) 1.27
SOD2 overexpression: enhanced mitochondrial tolerance but absence of effect on UCP activity. EMBO J (2005) 1.26
Intronic RNAs constitute the major fraction of the non-coding RNA in mammalian cells. BMC Genomics (2012) 1.26
Plasmid selection in Escherichia coli using an endogenous essential gene marker. BMC Biotechnol (2008) 1.25
Genetic evidence for inhibition of bacterial division protein FtsZ by berberine. PLoS One (2010) 1.24
The translation start codon region is sensitive to antisense PNA inhibition in Escherichia coli. Oligonucleotides (2003) 1.24
Genome-wide profiling of peroxisome proliferator-activated receptor γ in primary epididymal, inguinal, and brown adipocytes reveals depot-selective binding correlated with gene expression. Mol Cell Biol (2012) 1.22
RNA interference is not involved in natural antisense mediated regulation of gene expression in mammals. Genome Biol (2006) 1.21
Concurrent growth rate and transcript analyses reveal essential gene stringency in Escherichia coli. PLoS One (2009) 1.20
Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes. J Clin Endocrinol Metab (2003) 1.19
Separation effect and perception of pain and discomfort from two types of orthodontic separators. World J Orthod (2004) 1.19
Altered regulation of the PINK1 locus: a link between type 2 diabetes and neurodegeneration? FASEB J (2007) 1.19
Using transcriptomics to identify and validate novel biomarkers of human skeletal muscle cancer cachexia. Genome Med (2010) 1.18
Expression profiling following local muscle inactivity in humans provides new perspective on diabetes-related genes. Genomics (2005) 1.18
Hormone-induced mitochondrial fission is utilized by brown adipocytes as an amplification pathway for energy expenditure. EMBO J (2014) 1.18